Printer Friendly
The Free Library
14,709,930 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BIGMAR GETS BRAZILIAN APPROVAL TO MARKET FLUOROURACIL.


Bigmar Inc. (Nasdaq:BGMR BGMR Bigmar Inc. (stock symbol) ), Johnstown, Ohio Johnstown is a village in Licking County, Ohio, United States. The population was 3,440 at the 2000 census.

Johnstown was the home of William A. Ashbrook, an American businessman, newspaper publisher, and Democratic politician from Ohio.
, has received approval from Brazil's Agencia Nacional de Vigilancia Sanitaria (ANVS ANVS Agência Nacional de Vigilância Sanitária (National Sanitary Surveillance Agency; Brazil)
ANVS Algemene Nederlandse Vereniging van Schuldbemiddelaars (Dutch: Professional diligence in indebtments) 
) to market 5-fluorouracil in Brazil.

A potent anticancer agent, 5-fluorouracil is used in combination with other drugs to treat ovarian ovarian /ovar·i·an/ (o-var´e-an) pertaining to an ovary or ovaries.

ovarian

pertaining to an ovary.


ovarian agenesis
 and breast cancer. The ANVS action marks the first oncological product approval received by Bigmar in Brazil.

"We intend to market 5-fluorouracil under the Bigmar label," said John G. Tramontana, chairman and chief executive officer. "We anticipate receiving ANVS approvals for additional oncology products during 2000.

"The anticancer market in Brazil is growing at a substantial rate," Tramontana added. "We hope to capture a material share of the generic business in the near term."

Bigmar is a manufacturer of generic pharmaceutical oncology products and intravenous infusion solutions, which it manufactures at its state-of-the-art facilities in Switzerland. The company markets its products through partnerships of pharmaceutical distributors in Europe and the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and focuses on off-patent oncological pharmaceuticals. For more information, visit the company's Web site, www.bgmr.com or call 740/966-5800.
COPYRIGHT 2000 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:BIGMAR GETS BRAZILIAN APPROVAL TO MARKET FLUOROURACIL.
Publication:Worldwide Biotech
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 1, 2000
Words:170
Previous Article:BABIES TO BE SCREENED FOR DIABETES RISK GENES IN SWEDEN.(Brief Article)
Next Article:NATIONAL RESEARCH COUNCIL OF CANADA ACCEPTS AUTOMATED LAB.(Brief Article)
Topics:



Related Articles
Therapy improves rectal cancer outlook. (combination of radiation and drugs)
SWISS IKS APPROVES FORMULATION OF METRONIDAZOLE IN IV BAGS.(Brief Article)
The Spectacle of the Races: Scientists, Institutions, and the Race Question in Brazil, 1870-1930.(Review)
Corrections.(Correction Notice)
FDA APPROVES DRUG TO COMBAT PANCREAS CANCER.(BUSINESS)(Statistical Data Included)
Correction.(Brief Article)
FDA approves Eloxatin for colorectal cancer.(Pamphlet)
Editorial.(men's magazines)
Hallucinogenic tea: a constitutional right?(catholic tastes)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles